Market Research Logo

Global Cancer Gene Therapy Market 2017-2021

Global Cancer Gene Therapy Market 2017-2021

About Cancer Gene Therapy

Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual's body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy, gene transfer, and gene-induced immunotherapy. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses.

Technavio’s analysts forecast the global cancer gene therapy market to grow at a CAGR of 20.63% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer gene therapy market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Cancer Gene Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Adaptimmune
  • bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics
Other prominent vendors
  • Altor BioScience
  • Amgen
  • argenx
  • BioCancell
  • GlaxoSmithKline
  • Merck
  • OncoGenex Pharmaceuticals
  • Transgene
Market driver
  • Rising geriatric population
  • For a full, detailed list, view our report
Market challenge
  • High cost of gene therapy treatment
  • For a full, detailed list, view our report
Market trend
  • Favorable government regulations for gene therapy programs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


  • Executive summary
  • Scope of the report
  • Research Methodology
  • Market landscape
    • Market outline
      • Table Approaches for gene therapy
      • Table Difference between somatic cell and germline cell gene therapy
      • Table Major diseases treatment studies done through gene therapy
    • Market overview
      • Table Global cancer gene therapy market snapshot
    • Market size and forecast
      • Table Global cancer gene therapy market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline analysis
    • Table Pipeline molecules by vendors
    • Table Key clinical trials
  • Market segmentation by therapy
    • Table Segmentation of global cancer gene therapy market by therapy 2016
    • Table Segmentation of global cancer gene therapy market by therapy 2016 and 2021 (%)
    • Oncolytic virotherapy
      • Table Process involved in oncolytic virotherapy
      • Table Global cancer gene therapy market by oncolytic virotherapy 2016-2021 ($ millions)
      • Table Percentage of various viruses used in the clinical trials of oncolytic virotherapy for different cancer types
      • Table Oncolytic virotherapy scenario through adenovirus
      • Table Ideal characteristics of oncolytic virotherapy
    • Gene transfer
      • Table Global cancer gene therapy market by gene transfer 2016-2021 ($ millions)
      • Table Selected transferred genes under studies
    • Gene-induced immunotherapy
      • Table Global cancer gene therapy market by gene-induced immunotherapy 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Segmentation of global cancer gene therapy market based on geography 2016 and 2021
    • Table Global cancer gene therapy revenue by geography 2016-2021 ($ millions)
    • Cancer gene therapy in Americas
      • Table Market scenario in Americas
      • Table Cancer gene therapy market in Americas 2016-2021 ($ millions)
      • Table Gene therapy research institutes in the US and Canada
    • Cancer gene therapy market in EMEA
      • Table Market scenario in EMEA
      • Table Cancer gene therapy market in EMEA 2016-2021 ($ millions)
      • Table Commercialization status of gene therapy in top five European countries (as of November 2016)
      • Table Gene therapy research institutes in Europe focusing on cancer treatment
    • Cancer gene therapy market in APAC
      • Table Market scenario in APAC
      • Table Cancer gene therapy market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Common side effects associated with the treatment of cancer with traditional methods
      • Table Side effects associated with oncology drugs
      • Table General side effects of radiotherapy
      • Table Potential advantages of gene therapy in cancer treatment
    • Market challenges
      • Table Potential risks of cancer gene therapy
      • Table Case study: Major adverse event that bought halt in the gene therapy clinical trial scenarios
  • Market trends
    • Partnerships and collaborations are changing the market scenario
    • Favorable government regulations for gene therapy programs
  • Vendor landscape
    • Table Competitive structure analysis of global cancer gene therapy market
  • Key vendor analysis
    • Adaptimmune
      • Table Adaptimmune: Key highlights
      • Table Adaptimmune: Strength assessment
      • Table Adaptimmune: Strategy assessment
      • Table Adaptimmune: Opportunity assessment
    • bluebird bio
      • Table bluebird bio: Key highlights
      • Table Exhibit 42: bluebird bio: Strength assessment
      • Table bluebird bio: Strategy assessment
      • Table bluebird bio: Opportunity assessment
    • Celgene
      • Table Celgene: Key highlights
      • Table Celgene: Strength assessment
      • Table Celgene: Strategy assessment
      • Table Celgene: Opportunity assessment
    • Shanghai Sunway Biotech
      • Table Shanghai Sunway Biotech: Key highlights
      • Table Shanghai Sunway Biotech: Strength assessment
      • Table Shanghai Sunway Biotech: Strategy assessment
      • Table Shanghai Sunway Biotech: Opportunity assessment
    • Shenzhen SiBiono GeneTech
      • Table Shenzhen Sibiono GeneTech: Strength assessment
      • Table Shenzhen Sibiono GeneTech: Strategy assessment
      • Table Shenzhen Sibiono GeneTech: Opportunity assessment
    • SynerGene Therapeutics
      • Table SynerGene Therapeutics: Strength assessment
      • Table SynerGene Therapeutics: Strategy assessment
      • Table SynerGene Therapeutics: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report